1. Artificial surfactant therapy in hyaline membrane disease;T, I.Fujiwara; S, Chida; Y, Watabe; H, Maeta; T, Morita; T, Abe;Lancet,1980
2. Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial;Hallman, M.; Merritt, T.A.; Jarvenpaa, A.L.;J Pediatr,1985
3. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant. A randomized clinical trial;Enhorning, G.; Shennan, A.; Possmayer, F.; Dunn, M.; Chen, C.P.; Milligan, J.;Pediatrics,1985
4. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyalinie membrane disease in extremely premature infants;Kwong, S.M.; Egan, E.A.; Notter, R.H.; Shapiro, D.L.;Pediatnics,1985
5. Double blind, randomized trial of calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome;Shapiro, D.L.; RH, Notter; Morin, F.C.;Pediatrics,1985